Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prothrombin complex concentrates: a brief review.

C M Samama1

  • 1Hotel-Dieu University Hospital, Department of Anaesthesiology and Intensive Care, Paris Cedex, France. marc.samama@htd.aphp.fr

European Journal of Anaesthesiology
|June 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Andexanet alfa for the reversal of factor Xa inhibitors.

Expert opinion on biological therapy·2019
Same author

User-friendly recommendations on antiplatelet agents: At last, a readable document.

Revista espanola de anestesiologia y reanimacion·2018
Same author

Use of factor concentrates for the management of perioperative bleeding: reply.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Early ambulation and prevention of post-operative thrombo-embolic risk.

Journal of visceral surgery·2016
Same author

Coagulation following major liver resection.

Anaesthesia·2016
Same journal

Diminished rest-activity rhythm is associated with postoperative complications and mortality: A prospective cohort study of UK Biobank participants.

European journal of anaesthesiology·2026
Same journal

Beyond mathematical models: Why vial sizes and water safety matter.

European journal of anaesthesiology·2026
Same journal

Femoral nerve neurolysis in frail older adults with hip fracture: aligning peri-operative care with palliative goals.

European journal of anaesthesiology·2026
Same journal

2025 ESAIC and ESPA Guidelines on neuromuscular block in children.

European journal of anaesthesiology·2026
Same journal

A systematic review of efforts to predict day of surgery cancellation.

European journal of anaesthesiology·2026
Same journal

Precision anaesthesia: A paradigm shift in patient care.

European journal of anaesthesiology·2026
See all related articles

Prothrombin complex concentrates (PCCs) effectively reverse vitamin K antagonist effects and control bleeding. Further high-evidence studies are needed for indications like massive hemorrhage.

Area of Science:

  • Hematology
  • Pharmacology

Background:

  • Prothrombin complex concentrates (PCCs) are hemostatic blood products containing vitamin K-dependent clotting factors II, VII, IX, and X.
  • PCCs serve as a rapid alternative to fresh frozen plasma for reversing oral anticoagulant effects and for factor replacement in deficiency states.
  • Widely used in Europe, PCCs have demonstrated efficacy in normalizing coagulation and managing severe bleeding, with primarily thromboembolic events reported as rare side effects.

Purpose of the Study:

  • To review the efficacy and safety of prothrombin complex concentrates.
  • To discuss the role of PCCs in reversing vitamin K antagonist therapy and managing bleeding.
  • To highlight the need for high-evidence prospective studies in new indications, such as massive bleeding management.

Main Methods:

Related Experiment Videos

  • Review of retrospective and prospective studies on PCC efficacy and safety.
  • Analysis of reported side effects, particularly thromboembolic events.
  • Assessment of current and potential future indications for PCC use.

    • Main Results:

    • PCCs are effective in normalizing coagulation and controlling life-threatening bleeding.
    • Thromboembolic events are the main reported side effects, though their direct link to PCCs is often debated.
    • PCCs are a reliable and fast alternative to fresh frozen plasma for specific indications.

    Conclusions:

    • Prothrombin complex concentrates are valuable hemostatic agents with proven efficacy.
    • The association between PCCs and thromboembolic events requires careful consideration and further investigation.
    • Prospective studies are essential to establish the efficacy and safety of PCCs in high-risk settings like massive bleeding.